Thomson DJ, Ho KF, Ashcroft L, Denton K, Betts G, Mais KL, et al. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma. AO [Internet]. 2015 Jan. 2 [cited 2026 May 20];54(1):88-9. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25772